LOBULAR BREAST CARCINOMA IN SITU
Clinical trials for LOBULAR BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation may reduce arm swelling in breast cancer patients
Disease control OngoingThis study tests a shorter course of radiation (hypofractionated) to the breast and nearby lymph nodes in 137 women with node-positive breast cancer. The goal is to see if this approach reduces arm swelling (lymphedema) and other side effects while still preventing cancer from co…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common diabetes drug stop breast cancer before it starts?
Prevention OngoingThis phase 3 trial tests whether taking metformin for 12 months can reduce abnormal cells in the breast tissue of women at high risk for breast cancer. Participants have conditions like atypical hyperplasia or a strong family history. Researchers compare metformin to a placebo to…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Can online tools help women decide on breast cancer prevention?
Knowledge-focused OngoingThis study looks at whether web-based decision support tools can help women with atypical hyperplasia or lobular carcinoma in situ (conditions that raise breast cancer risk) make informed choices about chemoprevention. About 412 women and their healthcare providers will use educa…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC